Evidence map›Paper›PMID 26899254›Full record

ArticleBMJ open2016

Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study.

William T Gattrell, Sally Hopewell, Kate Young, Paul Farrow, Richard White, Elizabeth Wager, Christopher C Winchester

Abstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Professional writers can help to improve clarity of medical writing.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Preparing and Publishing a Scientific Manuscript.Journal of human reproductive sciences
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

William T GattrellResearch Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, UK Department of Mechanical Engineering and Mathematical Sciences, Oxford Brookes University, Oxford, UK.
Sally HopewellOxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.
Kate YoungResearch Evaluation Unit, Oxford PharmaGenesis Inc, Newtown, Pennsylvania, USA.
Paul FarrowResearch Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, UK.
Richard WhiteResearch Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, UK Department of Mechanical Engineering and Mathematical Sciences, Oxford Brookes University, Oxford, UK.
Elizabeth WagerSideview, Princes Risborough, UK University of Split School of Medicine, Split, Croatia.ORCID http://orcid.org/0000-0002-4202-7813
Christopher C WinchesterResearch Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, UK School of Medicine, Pharmacy and Health, Durham University, University Boulevard, Stockton-on-Tees, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAuthors may choose to work with professional medical writers when writing up their research for publication. We examined the relationship between medical writing support and the quality and timeliness of reporting of the results of randomised controlled trials (RCTs).

designCross-sectional study. STUDY SAMPLE: Primary reports of RCTs published in BioMed Central journals from 2000 to 16 July 2014, subdivided into those with medical writing support (n=110) and those without medical writing support (n=123).

main outcome measuresProportion of items that were completely reported from a predefined subset of the Consolidated Standards of Reporting Trials (CONSORT) checklist (12 items known to be commonly poorly reported), overall acceptance time (from manuscript submission to editorial acceptance) and quality of written English as assessed by peer reviewers. The effect of funding source and publication year was examined.

resultsThe number of articles that completely reported at least 50% of the CONSORT items assessed was higher for those with declared medical writing support (39.1% (43/110 articles); 95% CI 29.9% to 48.9%) than for those without (21.1% (26/123 articles); 95% CI 14.3% to 29.4%). Articles with declared medical writing support were more likely than articles without such support to have acceptable written English (81.1% (43/53 articles); 95% CI 67.6% to 90.1% vs 47.9% (23/48 articles); 95% CI 33.5% to 62.7%). The median time of overall acceptance was longer for articles with declared medical writing support than for those without (167 days (IQR 114.5-231 days) vs 136 days (IQR 77-193 days)).

conclusionsIn this sample of open-access journals, declared professional medical writing support was associated with more complete reporting of clinical trial results and higher quality of written English. Medical writing support may play an important role in raising the quality of clinical trial reporting.

Indexed as

Randomized Controlled Trials as TopicChecklistCross-Sectional StudiesHumansMedical WritingPilot ProjectsPublishingResearch ReportCONSORTMedical writingPeer reviewQualityRandomised controlled trials

Identifiers

PMID26899254
PMCPMC4762118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.